-35.3%
QXO vs EMR
+19.4%
-54.8%
-52.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | +1.7% | -2.6% | -2.7% |
| 7D | -1.3% | -1.5% | +0.3% | +0.3% |
| 30D | -16.0% | -5.6% | -10.4% | -10.7% |
| 3M | -17.7% | +7.9% | -25.7% | -23.5% |
| 6M | -42.6% | +6.0% | -48.6% | -46.0% |
| YTD | -30.8% | +16.4% | -47.2% | -43.0% |
| 1Y | -35.3% | +16.6% | -51.9% | -47.1% |
| All | -35.3% | +19.4% | -54.8% | -47.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling